Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 49,859 | 38,012 | 30,855 | 45,140 | 10,519 |
| Gross Profit | 49,859 | 38,012 | 30,855 | 45,140 | 10,519 |
| Operating Expenses | 70,985 | 68,424 | 49,127 | 64,454 | 65,893 |
| Operating Income | -21,126 | -30,412 | -18,272 | -19,314 | -55,374 |
| Interest Expense | -4,148 | 53 | -9,686 | -3,981 | -3,252 |
| Other Income | -388 | 4,016 | -2,859 | 4 | 149 |
| Pre-tax Income | -17,366 | -26,449 | -11,445 | -15,329 | -51,973 |
| Income Tax | -150 | 368 | 262 | 893 | 577 |
| Net Income Continuous | -17,216 | -26,817 | -11,707 | -16,222 | -52,550 |
| Net Income | $-17,216 | $-26,817 | $-11,707 | $-16,222 | $-52,550 |
| EPS Basic Total Ops | -0.64 | -1.00 | -0.44 | -0.61 | -1.98 |
| EPS Basic Continuous Ops | -0.64 | -1.00 | -0.44 | -0.61 | -1.98 |
| EPS Diluted Total Ops | -0.64 | -1.00 | -0.40 | -0.61 | -1.98 |
| EPS Diluted Continuous Ops | -0.64 | -1.00 | -0.40 | -0.61 | -1.98 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -1.00 | -0.32 | -0.61 | -1.98 |
| EBITDA(a) | $-20,217 | $-29,508 | $-17,457 | $-18,487 | $-54,637 |